Use of inhibitors of gag synthesis for the treatment of corneal haze
US6399107B1 · kind B1 · utility
3Cited by
16References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2001 |
| Grant date | Jun 4, 2002 |
| Priority date | — |
| Expiry date | Jun 20, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the compositions and methods for the treatment of corneal haze. The compositions and methods are particularly directed to the use of GAG synthesis inhibitors in the treatment of corneal haze.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.